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Abstract Cystinosis is a rare multisystemic progressive
disorder mandating lifelong medical treatment. Knowledge
on the intellectual and motor functioning, health-related
quality of life and psychosocial adjustment in children with
cystinosis is limited. We have investigated nine patients
(four after renal transplantation) at a median age of
9.7 years (range 5.3–19.9 years). Intellectual performance
(IP) was analysed with the Wechsler Intelligence Scale for
Children-III (seven children) and the Kaufman Assessment
Battery for Children (two children). Motor performance
(MP) was evaluated using the Zurich Neuromotor Assess-
ment Test, and quality of life (QOL) was studied by means
of the Netherlands Organization for Applied Scientific
Research Academical Medical Center Child Quality of Life
Questionnaire. Psychosocial adjustment was assessed by
the Child Behavior Checklist. The overall intelligence
quotient (IQ) of our patient cohort (median 92, range 71–
105) was significantly lower than that of the healthy
controls (p=0.04), with two patients having an IQ<85.
Verbal IQ (93, range 76–118) was significantly higher than
performance IQ (90, range 68–97; p=0.03). The MP was
significantly below the norm for pure motor, pegboard and
static balance, as well as for movement quality. The
patients’ QOL was normal for six of seven dimensions
(exception being positive emotions), whereas parents
reported significant impairment in positive emotions,
autonomy, social and cognitive functions. Significant
disturbance was noted in terms of psychosocial adjustment.
Based on the results from our small patient cohort, we
conclude that intellectual and motor performance, health-
related QOL and psychosocial adjustment are significantly
impaired in children and adolescents with cystinosis.
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Introduction
Cystinosis is a rare, multisystemic autosomal recessive
disorder characterized by a defective lysosomal transport
of cystine leading to intralysosomal cystine accumulation
[1–7]. The disease is attributed to mutations in the CTNS
gene encoding cystinosin [4]. Pathogenetic mechanisms
include impaired mitochondrial function [8], defective
Na+-dependent cotransporters [9] and increased apoptosis
rate [8, 10]. Cysteamine is the only therapeutic agent known
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to be effective in depleting the intra-lysosomal accumulation
of cystine, but endstage renal failure is still common during
the second decade of life in many patients [1, 3].
Chronic renal disease has been associated with impairments
in neurocognitive outcome and quality of life (QOL) [11, 12].
Limited information is available on adults with cystinosis in
terms of intellectual performance (IP), motor performance
(MP), QOL and psychosocial adjustment (PA). Children with
cystinosis have been found to have of visual processing
impairment [13], poor arithmetic performance [14] and mild
intellectual deficits [15], but little is known on the MP, QOL
and PA of children with this condition. However, children with
chronic kidney diseases of various origins are at risk of
impaired PA [16], externalizing behavioural problems and
impaired QOL [12, 17–19]. We have previously reported
neurocognitive outcome and QOL in those children using
standardized and validated assessment tests and questionnaires
[11, 12, 20].
The aim of this case series was to assess IP, MP, QOL
and PA in nine children and adolescents with cystinosis. We
also performed cerebral magnetic resonance imaging (MRI)
to assess central nervous system (CNS) pathology (e.g.
atrophy, calcifications, benign intracranial hypertension).
Patients and methods
Patients
Since 1970, 11 patients with cystinosis have been followed
at the University Children’s Hospital in Zurich. Two
patients died since the initiation of the study: one within
24 h of renal transplantation (RTPL) due to acute heart
failure, and the other succumbed to spinalioma 11 years
after RTPL. Nine patients (four girls, five boys) from eight
families were therefore included in this study, four of whom
had had RTPL (Table 1).
Diagnosis was made based on cystine content in white
blood cells. Medical treatment consisted of cysteamine
(60 mg/kg per day given in four to five doses) in all
patients; white blood cystine content was not measured
routinely. Before RTPL, further medication included oral
electrolytes, i.e. sodium, potassium, phosphorus and
bicarbonate (all patients), 1,25-dihydroxycholecalciferol
(all patients), L-thyroxine for hypothyrodism (patients B,
C, F, I), recombinant erythropoietin (A, C, E) and human
growth hormone (A, B, C). None of the patients were
diagnosed with diabetes mellitus or with a significant visual
impairment.
After RTPL, immunosuppression consisted of cyclosporine
A (G, H, I; trough level 80–120 ng/ml) or tacrolimus (F; trough
level 4–8 ng/ml), mycophenolate mofetile (G, H; daily dose
of 1200 and 900 mg/m2 body surface in patients on
cyclosporine A and tacrolimus, respectively) or azathioprine
(F, I; dose 1 mg/kg body weight). One patient (I) was on low-
dose alternate-day prednisone (7.5 mg), and three patients (F,
G, H) were off steroids. Patients G and I were on
antihypertensive medication.
The following parameters were analysed: (1) casual
blood pressure, measured in the sitting position targeting
systolic blood pressure <95th percentile [21], (2) glomer-
ular filtration rate (GFR, estimated by the Schwartz
formula [22] with a k-factor of 40 based on comparison
with creatinine (Cr)-EDTA clearance measurements), (3)
audiometry, (4) body weight and body height and (5) body
mass index (BMI).
One patient (I) had developed post-transplant lympho-
proliferative disorder (PTLD) (B-non-Hodgkin lymphoma
stage III) 2 years after RTPL; chemotherapy and reduction
of immunosuppressive therapy resulted in long-term
remission.
Seven children lived with both parents; the parents of
patient H were divorced. Seven families were Swiss, and
one family (D) was Portuguese.
Patient/sex Age at evaluation
(years)
Age at diagnosis
(years)
Age at RTPL/Type
of donor (years)
GFR (ml/min
per 1.73 m2)
A/female 5.3 1.1 - 46
B/femalea 5.7 0.1 - 85
C/femalea 9.2 1.6 - 44
D/femaleb 9.3 4.3 - 64
E/male 9.7 1.8 - 20
F/male 11.8 1.8 7.1/LRD 61
G/male 13.3 3.8 9.4/LRD 83
H/male 15.8 1.1 13.5/LRD 56
I/malec 19.9 5.3 12.5/CD 31
Table 1 Clinical data
RTPL, Renal transplantation;
LRD, living related donor; CD,
cadaveric donor; GFR, glomer-
ular filtration rate (estimated by
the Schwartz formula) [22]
a Siblings
b Nephropathic cystinosis and
cystic fibrosis [35]
c Post-transplant lymphoprolifer-
ative disorder (PTLD)
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Methods
Intellectual performance
The Wechsler Intelligence Scale for Children (WISC-III)
[23, 24] was given to seven patients, all of school age
(C–I). The WISC-III is used in children aged 6–16 years
and is summarized in three intelligence quotient (IQ)
scales, full scale (FSIQ), verbal (VIQ) and performance
(PIQ), with a mean score of 100 and a standard deviation
(SD) of 15. One young adult (I) was also tested with the
WISC-III to obtain test results for comparison purposes.
Two children <6 years of age (A and B) were assessed
with the German version of the Kaufman Assessment
Battery for Children (K-ABC) [25, 26]. The K-ABC is used
in preschool and school-aged children. It is composed of
two scales, the mental processing composite and the
achievement scale.
Motor performance
Motor performance was assessed with the Zurich Neuro-
motor Assessment (Z-NMA) [27, 28], a standardized
testing procedure assessing timed MP and movement
quality in children aged 5–18 years.
Eight of the nine children performed the motor test; one
child did not cooperate sufficiently to obtain reliably timed
results. Motor performance is divided into four timed compo-
nents based on the complexity of the motor task (pure motor,
pegboard, dynamic and static balance) and one component that
assesses movement quality by measuring associated move-
ments. We transformed the raw data into individual deviations
from these age-adjusted normative values, which are expressed
as standard deviations scores (SDS) [27, 28].
Cerebral MRI and spectroscopy
Magnetic resonance imaging was performed on eight
patients using standard imaging protocols, including
multiplanar T1-weighted spin-echo and T2-weighted fast
spin-echo images covering the brain from the skull base to
the vertex. It could not be performed on one child because
of logistic problems. Diffusion-weighted MRI and 1H
magnetic resonance spectroscopy (MRS) results were
available for four children. All images were obtained using
a 1.5-Tesla MRI unit (General Electric Medical Systems,
Milwaukee, WI) and were evaluated by two paediatric
neuroradiologists. The ventricles and subarachnoid space
were rated using an arbitrary scaling system as (1) normal,
(2) mildly enlarged, (3) moderately enlarged or (4)
significantly enlarged. In addition, the perivascular Virchow
Robin spaces were evaluated and graded as either (1)
normal or (2) prominent. Moreover, the cerebral white
matter was evaluated for focal white matter lesions, the
degree of white matter myelination (delayed, age appropriate
or accelerated) and calcifications.
The TNO–AZL child quality of life questionnaire
The Netherlands Organization for Applied Scientific Re-
search Academical Medical Center (TNO–AZL) Child
Quality of Life Questionnaire (TACQOL) [29] comes in
two forms, one for the parent and one for the child; both are
designed to assess the QOL in children aged 8–15 years
with chronic diseases. The questionnaire consists of seven
scales assessing physical complaints (Body), cognitive
(Cognition), social functioning (Social), autonomy (Auto),
basic motor function (Motor), global positive emotional
functioning (Emotion positive) and global negative emo-
tional functioning (Emotion negative), and its questions
focus on problems in these areas. The child’s emotional
response to the problem may also be assessed. The items
are scored on scale of 4–0 (4 = problem never occurred; 3 =
problem occurred, but child felt well; 2 = problem occurred,
but child did not feel well; 1 = problem occurred, child felt
rather badly; 0 = problem occurred, child felt badly). The
maximum score for the first five domains is 32, while 16 is
the maximum score for the emotional scales; the higher the
score, the better the QOL.
Studies on normal control and clinical populations have
confirmed the internal and external validity of the ques-
tionnaires [29, 30]. Normal values for the Child Form based
on results obtained from more than 2300 healthy Dutch
children aged 8–15 years (communicated by AGC Vogels,
Sept 15, 2006). Reference values for the Parent Form were
retrieved from the scale manual based on data from 1618
parents of healthy children aged 6–11 years [30].
Psychosocial adjustment
The Child Behavior Checklist (CBCL) is a standardized
measure with excellent psychometric properties that enable
a parent to report on a child’s behavior [31]. It consists of
120 items assessing internalizing (withdrawn, somatic
complaints, anxiety/depression, thought problems) and
externalizing behaviour scales (social problems, attention
problems, delinquent and aggressive behaviour). A total
behavioural problem score is calculated from these problem
scales, and this is compared with age- and sex-matched
normative data (T-score). A higher score indicates greater
child maladjustment. In this study, the German version of
the CBCL was used; reference values are based on results
obtained from 2865 healthy German children and adoles-
cents [32, 33].
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Procedure
The study was approved by the Ethical Committee of the
University Children’s Hospital of Zurich. Written informed
consent was obtained from either the patient (aged >18 years),
the parents or both. All nine patients tested for IP andMPwere
seen by the same paediatrician, who was not involved in the
patient’s care and unaware of current renal/graft function. The
examiner was monitored by video recordings. German trans-
lations of all QOL and PA questionnaires followed published
guidelines, including independent back-translation [34]. All
patients >6 years were interviewed by the same investigator
using the TACQOL–Child form. The TACQOL–Parent
Form was completed by all parents separately. The forms
were filled in either during the clinic visit in the hospital or at
home. Seven children returned the TACQOL–Child form (A,
B were too young), and eight parents returned the CBCL and
TACQOL–Parent form.
Statistical analysis
Statistical analysis was performed using the SPSS statistical
software package, vers. 11.5 (SPSS, Chicago, IL.). A value
of p ≤ 0.05 was considered to be significant. Results were
either presented as the mean and standard deviation (SD) or
as the median and range. For comparison between groups,
the Mann–Whitney–Wilcoxon U test was used; for com-
parison with norm values, the one-sample Wilcoxon signed
ranks test (IP, MP) and Student’s t test (QOL, PA) were
applied. Correlation analysis was performed using the
Spearman correlation.
Results
Clinical examination
Clinical data are summarized in Table 1. Patients were
examined at a median age of 9.7 years (range 5.3–
19.9 years). Two patients (G, I) required antihypertensive
treatment when the blood pressure was <95th centile.
Audiometry and neurological examination were normal in
all patients. One patient (D) had concomitant, yet clinically
mild cystic fibrosis [35], while another patient (I) had
recovered from PTLD.
Intellectual and motor performance
The overall median full scale IQ was 92 (range 71–105),
which was significantly lower than that of the normal
controls (p=0.04). No child was diagnosed with mental
retardation (IQ<70), however, two children (E, G) had IQ-
scores <85 (i.e. mean >1 SD) of 71 and 75, respectively.
With the exception of patient G, who was in a special
school for mentally handicapped children, all children were
in regular or nursery school. For those children examined
with the WISC-III (C–I), the PIQ (median 90; range 68–97)
was significantly lower than that of the normal controls (p=
0.01) and also significantly lower than the VIQ (median 93,
range 76–118, p=0.03) (Table 2).
The MP was significantly below the norm for all
components except dynamic balance (Table 3). In the
dynamic balance, the difference from the norm did not
reach statistical significance (Wilcoxon signed ranks test
p=0.08).
Quality of life questionnaire (TACQOL) and psychosocial
adjustment
The patients’ self-report of QOL was normal for six of the
seven dimensions, with the exception being positive emo-
tions, which were significantly impaired. The parents
reported significant impairment in positive emotions, auton-
omy, social and cognitive functions (Table 4). The PA was
significantly impaired, with higher scores on the internal-
izing, externalizing and total behavior scale of the CBCL
(Table 5).
Magnetic resonance imaging and spectroscopy
The results are summarized in Table 2. Incidental focal
findings included mesial sclerosis of the hippocampus in
one patient (G) and developmental venous anomaly in
another child (C). Four children were found to have mildly
or moderately enlarged ventricles. The MRI findings were
not related to IP or MP. Diffusion-weighted MRI and 1H
MRS did not show any additional pathology.
Discussion
Despite a growing understanding of the genetic, patho-
physiological and therapeutic aspects of cystinosis [1–7,
36–38], only limited information is available on the long-
term developmental and psychosocial outcome of this
disease. This study provides further information on intel-
lectual and motor performance (IP and MP), quality of life
(QOL) and psychosocial adjustment (PA) in children and
adolescents with cystinosis. The results of the standardized
tests used in this study demonstrate that the IP, MP and PA
of our patient cohort were significantly impaired. We also
found that parents rated their children’s QOL more
pessimistically than the children themselves.
Intellectual performance—performance (non-verbal) IQ
in particular—was affected. This finding is in line with
those from other studies, indicating that a significant
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proportion (65%) of children with chronic kidney disease
manifest developmental delay [17] and that performance IQ
is more impaired than verbal IQ [17]. Focusing on patients
with cystinosis, our results are in line with those of William
et al. [15], who demonstrated a significantly lower IQ in 15
patients compared to controls, with the most significantly
affected score being the item “spelling”. Ballantyne et al.
[14] evaluated academic achievement; these researchers
found that the patients had lower average IQ ranges on both
arithmetic (mean 89.95±13.77) and spelling skills (mean
90.68±18.81), while those for reading were higher (mean
97.47±15.59). Interestingly, all but one patient were in
regular school. This may indicate that despite the lower IQ
scores, the Swiss school system can accommodate these
children by either providing individualized teaching or
through an integration system where remedial schooling is
integrated in the regular school class. Visual functioning
has been extensively studied by Ballantyne et al. In one
study [13] they found that children with cystinosis may
manifest specific deficits in visuospatial functions. We did
not examine these specific functions; however, some
subtests of the WISC III performance IQ do assess
visuospatial functioning and, therefore, our results of a
lower performance IQ compared to the verbal IQ also
confirm the findings of Ballantyne et al. [13].
The MRI findings in our study included enlarged
ventricles and two incidental findings of mesial sclerosis
of the hippocampus and developmental venous anomaly.
The child with the mesial sclerosis of the hippocampus had
an IQ of 71, and there may be an association of these two
findings. The other structural MRI abnormalities were not
associated with cognitive and motor dysfunction, possibly
due, at least in part, to the small sample size. Importantly,
neither MR spectroscopy nor diffusion tensor imaging
revealed any abnormalities. Our results are in contrast to
those reported in one study which detected cortical atrophy
in the majority of patients. In that study, greater cortical
atrophy was related to lower cognitive performance [39].
This is the first published study to assess MP in patients
with cystinosis using a standardized assessment tool, i.e.
the Zurich Neuromotor Assessment [27, 28], which has the
advantage of providing a control group comprising healthy
age-related Swiss children. Impaired MP may result in
school problems related to fine motor difficulties, with
substantial negative effect on academic performance. Gross
motor difficulties may negatively affect peer interactions
and subsequently profoundly impair feelings of well being
and self-esteem. Few other studies have examined motor
performance in this population. General muscular hypoto-
nia has been a consistent finding in many children with
chronic kidney diseases of various origins [40]. Muscular
hypotonia can be associated with poorer motor perfor-
Table 2 Intellectual performance, magnetic resonance imaging findings and schooling situation
Patient Test FSIQ VIQ PIQ MRI Schooling
A K-ABC 97 Mildly enlarged ventricles Nursery school
B K-ABC 92 Normal Nursery school
C WISC-III 89 90 90 Normal Regular school
D WISC-III 92 93 91 No MRI available Regular school
E WISC-III 75 82 69 Normal Regular school
F WISC-III 100 104 97 Mildly enlarged ventricles widened
subarachnoidal space
Regular school
G WISC-III 71 76 68 Mesial temporal sclerosis Special school
H WISC-III 99 104 95 Moderately enlarged ventricles Regular school
I WISC-III 105 118 89 Moderately enlarged ventricles Completed high school,
apprenticeship
Median 92a 93 90b
K-ABC, Kaufman Assessment Battery for Children; WISC-III, Wechsler Intelligence Scale for Children; FSIQ, full scale intelligence quotient
(IQ); VIQ, verbal IQ; PIQ, performance IQ; MRI, magnetic resonance imaging
a p=0.04 (Wilcoxon signed ranks test compared to norm)
b p=0.01 (Wilcoxon signed ranks test compared to norm)
Table 3 Motor performance assessed with the Zurich Neuromotor
Assessment
Pure
motor
Peg-board Dynamic
balance
Static
balance
Movement
quality
Median −1.30* −0.55* −1.90 −1.10* −1.05*
Range −3.7 to
0.3
−2.3 to
−0.1
−4.8 to
1.3
−4.1 to
−0.3
−3.3 to
−0.5
*p<0.05 (Wilcoxon signed ranks test compared to healthy controls)
Values are given as standard deviation scores (SDS)
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mance, in particular with static balance tasks. One study
that examined motor performance in young children using
the Bayley Scales of Infant Development found that motor
development was abnormal in 24% of children transplanted
in early childhood [41]. Neurological co-morbidity was the
most negative predictor of poor motor performance [41].
It has been suggested that mutations in the CTNS gene
may influence brain development [42]. However, at least
two studies have been unable to find a correspondence
between intellectual development and cognitive functioning
and the degree of observed cerebral atrophy [39, 43].
Patients not treated with cystine-depleting agents have been
shown to suffer from ongoing cerebral atrophy [37]. In our
small series of patients, the white matter myelination
appeared to be normal on both the MRI and 1H MRS scans.
One of the limitations of our study is the small number
of patients, which limits the statistical power of our results.
The impact of cysteamine dosage on the general outcome
of our patients could not be assessed because white blood
cell cystine levels were not routinely measured, and
cysteamine dosage was maintained at 60 mg/kg per day.
Furthermore, patients were examined independent of RTPL
and, therefore, we could not analyse the effect of RTPL. In
addition, different intelligence tests were used to assess
intellectual performance. The results of the WISC-III and
the K-ABC are somewhat difficult to compare because of
different theoretical concepts. Assessing children at differ-
ent ages may also underscore the true extent of the
intellectual deficits since higher executive functions or
specific learning disabilities may not be detected at young
ages. Our results were compared to those of healthy control
children and not to children with renal diseases unrelated to
cystinosis. As such, we are unable to draw any conclusion
on the specific neurocognitive profile of children with
cystinosis in comparison to those with other renal disorders.
The self-reported QOL dimension of positive emotions of
our small patient cohort was impaired compared with that of
the healthy controls. For our patients with cystinosis, emo-
tional disturbance seemed to be more important than physical
complaints or motor functions; the parents also rated positive
emotions as being significantly impaired, but in contrast to the
assessment of their children, parents also rated autonomy,
Measure Sample Normative data [29] p value
Mean Standard deviation Mean Standard deviation
TACQOL-Child form
Body 26.2 4.3 24.2 5.0 0.25
Motor 30.7 1.5 29.8 3.2 0.16
Autonomy 30.1 1.9 31.4 1.9 0.13
Cognition 26.7 4.9 28.5 3.9 0.37
Social 27.4 3.2 29.4 2.7 0.16
Positive Emotion 10.9 2.5 13.3 2.5 0.04*
Negative Emotion 12.4 1.8 11.6 2.7 0.33
TACQOL-Parent form
Body 23 6.9 27.6 3.7 0.10
Motor 26.5 6.4 31 2.3 0.09
Autonomy 27* 4.3 31.4 1.6 0.05*
Cognition 21.5 7 29.2 3.7 0.04*
Social 26 4.8 30 2.3 0.05*
Positive Emotion 11.4 3 15 1.8 0.01*
Negative Emotion 11.0 2.5 11.7 2.3 0.46
Table 4 Quality of life assessed
by means of the Child Quality
of Life Questionnaire
TACQOL, Netherlands Organi-
zation for Applied Scientific
Research Academical Medical
Center (TNO–AZL) Child
Quality of Life Questionnaire
*p ≤ 0.05 compared with
normative data (according
to the t test)
Measure Sample Normative data [31] p value
Mean Standard deviation Mean Standard deviation
CBCL total score 63 7.5 50 10 0.002*
CBCL internalizing score 65.4 10.6 50 10 0.005*
CBCL externalizing score 57.5 5.2 50 10 0.005*
Table 5 Psychosocial adjust-
ment measured by means of the
Child Behaviour Checklist
*p ≤ 0.05 compared with norma-
tive data (according to the t test)
CBCL, Child Behaviour Checklist
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social and cognitive functions as being significantly impaired.
This divergent rating of patients and parents, especially the
tendency toward a more critical parental assessment, is
noteworthy. This tendency has been observed in other
chronically ill paediatric populations, such as in children with
congenital heart disease after open-heart surgery [44], paedi-
atric renal graft recipients [11] and children with relapsing
diseases (steroid-sensitive nephrotic syndrome) [12]. This
finding might reflect a shared variance between a mothers’
psychological strain and the rating of her child’s QOL [45].
Parents may have a different awareness of the impact of their
child’s chronic disease. Alternatively, affected patients may
have scored their QOL too optimistically because of
confusing factors (e.g. face-to-face interview, mechanisms
of avoidance). We could not define any correlations between
co-morbidity (e.g. hypothyroidism) and cysteamine treatment.
In contrast to other patients with chronic disorders, such
as phenylketonuria or paediatric burn survivors [32, 33],
patients with cystinosis showed both internalizing and
externalizing disturbances. The patients’ main complaints
were directed against withdrawn, somatic complaints,
anxiety, depression, attention problems and aggressive
behaviour. These complaints may reflect the profound
effect of the disorder and underlines the importance of
these patients receiving adequate, supportive and compre-
hensive treatment. Our results were similar to those
reported for children with relapsing steroid-sensitive ne-
phrotic syndrome [12]. One explanation for this in steroid-
sensitive nephrotic syndrome may be the adverse effects of
steroids or the constant fear of imminent relapse by the
parents [12]. In cystinosis, other reasons may be causal:
patients need a life-long medical treatment, there is no
curative treatment available to date, and, in particular, the
long-term prognosis (e.g. diabetes mellitus, hypothy-
roidism, neurological and muscular complications) is poor
despite life-long therapy [1].
It was not possible to define any determinants for QOL
and PA in our cohort, as the number of patients was too
small, although QOL seemed to improve after renal
transplantation. However, our results do not include the
progression of the multisystemic disorder, in particular the
development of the brain and the muscular system. Further
studies evaluating long-term outcome are required.
In patient D, who suffered from cystic fibrosis and
cystinosis, results concerning QOL and PA were comparable
with that of the other patients. This may indicate that the co-
morbidity cystic fibrosis did not further impact onQOL and PA.
In summary, this observational study on children and
adolescents with cystinosis suggests that intellectual
performance, motor performance, health-related quality of
life and psychosocial adjustment are impaired, thereby
reflecting the extent of potential sequelae of this multi-
systemic disorder.
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